While TZDs are effective in lowering hyperglycemia, largely by an insulin sensitizing action [7], [8], concerns over the adverse effects of TZDs on an increased risk of heart failure [9] and bladder cancer [10] have restricted their long-term use. The gene discussed is INS; the disease is Hyperglycemia.